Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.003 per share
-
Shares outstanding
-
792,553,191
-
Total 13F shares
-
99,471,712
-
Share change
-
+1,489,446
-
Total reported value
-
$204,984,259
-
Put/Call ratio
-
8%
-
Price per share
-
$2.06
-
Number of holders
-
82
-
Value change
-
-$1,910,639
-
Number of buys
-
36
-
Number of sells
-
39
Institutional Holders of Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) as of Q3 2025
As of 30 Sep 2025,
Mereo BioPharma Group plc - Ordinary Shares, par value GBP 0.003 per share (MREO) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,471,712 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Rubric Capital Management LP, Frazier Life Sciences Management, L.P., MANGROVE PARTNERS IM, LLC, Aberdeen Group plc, 683 Capital Management, LLC, Rock Springs Capital Management LP, Clearline Capital LP, ALKEON CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
82
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.